
Dupilumab-Treated Patients with Atopic Dermatitis at Increased Risk of Psoriasis
Individuals with atopic dermatitis being treated with dupilumab are at an increased risk of developing psoriasis, new findings suggest, compared to individuals receiving other systemic drugs.1 These data were the result of a recent analysis authored by a …